Inhibikase Therapeutics, Inc. (IKT) Institutional Ownership

Institutions by Trading Activity

Ownership Statistics

91,771,385Shares Outstanding

11,293,328Shares held by institutions

$19,085,724Value of institutional holdings

115.28%Institutional ownership %

92.75%Shares Changed QoQ

70No. of institutional investors

Shares Owned by Institutions

Shares Purchased/Sold by Institutions

Ownership Summary

The institutional landscape for Inhibikase Therapeutics, Inc. (NASDAQ:IKT) includes 70 filers as of the latest reporting cycle ending December 2025.

The percentage of Inhibikase Therapeutics owned by institutions changed from 59.9% in September 2025 to 115.3% in December 2025, marking a slight up trend.
Quarterly data indicates a 92.75% shift in institutional share volume, and the annual owner count reflects an increase of 118.75%.
The latest 13F cycle for Inhibikase Therapeutics reveals that of 70 total investors, 46 funds grew their exposure, whereas 14 reduced theirs and 10 made no changes.
Collectively, institutional investors increased their stake in Inhibikase Therapeutics to 105.80Mn shares as of December 2025, a change that is up by 50.91Mn shares quarter on quarter and up 55.74Mn shares year over year.
With 13.02Mn shares, Sands Capital Alternatives, LLC commands the largest institutional position in Inhibikase Therapeutics as of December 31, 2025, equating to 14.19% of the company.
Among the most significant buyers of Inhibikase Therapeutics during December 2025 were Trails Edge Capital Partners, LP (6.18Mn), Siren, L.L.C. (5.85Mn), Soleus Capital Management, L.P. (4.55Mn), Squadron Capital Management LLC (4.22Mn), Saturn V Capital Management LP (3.86Mn).
Leading sellers of Inhibikase Therapeutics stock in December 2025 included NORTHERN TRUST CORP (51.62K), FMR LLC (48.40K), UBS Group AG (41.73K), DEUTSCHE BANK AG\ (25.59K), JPMORGAN CHASE & CO (25.09K).
The top 10 institutional holders of Inhibikase Therapeutics for the quarter ending December 2025 included Sands Capital Alternatives, LLC (13.02Mn), Soleus Capital Management, L.P. (10.88Mn), Fairmount Funds Management LLC (8.62Mn), ADAR1 Capital Management, LLC (8.06Mn), Trails Edge Capital Partners, LP (6.18Mn), Blackstone Inc. (5.94Mn), Siren, L.L.C. (5.85Mn), PERCEPTIVE ADVISORS LLC (5.42Mn), Commodore Capital LP (5.40Mn), VANGUARD GROUP INC (4.56Mn).

70 Institutional Holders

11,293,328 Total Shares Held

Rows:

Download Data

Owner Name	Date	Shares Held	Change (QoQ)	Change (%)	Value (USD)
Sands Capital Alternatives, LLC	31 Dec, 2025	13,018,965	2,068,965	18.89%	$26,688,878.00
Soleus Capital Management, L.P.	31 Dec, 2025	10,875,000	4,550,000	71.94%	$22,293,750.00
Fairmount Funds Management LLC	31 Dec, 2025	8,625,000	2,500,000	40.82%	$17,681,250.00
ADAR1 Capital Management, LLC	31 Dec, 2025	8,063,949	2,816,346	53.67%	$16,531,095.00
Trails Edge Capital Partners, LP	31 Dec, 2025	6,178,124	6,178,124	0.00%	$12,665,154.00
Blackstone Inc.	31 Dec, 2025	5,938,276	3,300,000	125.08%	$12,173,466.00
Siren, L.L.C.	31 Dec, 2025	5,850,000	5,850,000	0.00%	$11,992,500.00
PERCEPTIVE ADVISORS LLC	31 Dec, 2025	5,421,568	0	0.00%	$11,114,214.00
Commodore Capital LP	31 Dec, 2025	5,397,488	0	0.00%	$11,064,850.00
VANGUARD GROUP INC	31 Dec, 2025	4,558,604	1,285,265	39.26%	$9,345,138.00
Squadron Capital Management LLC	31 Dec, 2025	4,225,000	4,225,000	0.00%	$8,661,250.00
Nantahala Capital Management, LLC	31 Dec, 2025	3,929,292	1,739,292	79.42%	$8,055,049.00
Saturn V Capital Management LP	31 Dec, 2025	3,856,799	3,856,799	0.00%	$7,906,438.00
Spruce Street Capital LP	31 Dec, 2025	3,581,603	3,581,603	0.00%	$7,342,286.00
BlackRock, Inc.	31 Dec, 2025	3,305,574	230,388	7.49%	$6,776,427.00
Stonepine Capital Management, LLC	31 Dec, 2025	2,348,147	1,613,128	219.47%	$4,813,701.00
Integral Health Asset Management, LLC	31 Dec, 2025	1,750,000	1,750,000	0.00%	$3,587,500.00
Kalehua Capital Management LLC	31 Dec, 2025	1,750,000	1,750,000	0.00%	$3,587,500.00
AMERIPRISE FINANCIAL INC	31 Dec, 2025	1,376,395	1,376,395	0.00%	$2,821,610.00
CITADEL ADVISORS LLC	31 Dec, 2025	1,243,630	1,171,960	1,635.22%	$2,549,441.00

1 - 20 of 70

Research Tools